intermittent claudication/nausea

Veza se sprema u međuspremnik

Odaberite vrstu sortiranja

13 rezultatima

Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up before

Pentoxifylline in the treatment of intermittent claudication of the lower limbs.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Pentoxifylline, a methyl xanthine analogue was evaluated for treatment of intermittent claudication in a double-blind placebo controlled parallel group study in seven centers in the United States. Tests were performed on 128 cases, including 42 who took pentoxifylline (600 mg by mouth daily,

Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Prostacyclin is an endothelially derived vasodilator and inhibitor of platelet aggregation. Despite its therapeutic potential for peripheral arterial disease, the short half-life and chemical instability are barriers to routine therapy. Accordingly, prostacyclin analogs are being evaluated in

Pharmacologic treatment of intermittent claudication.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Twenty-six patients with severe short-distance claudication underwent a 24-week, randomized, double-blind, parallel-group evaluation of the efficacy of pentoxifylline in the treatment of intermittent claudication. The primary variables analyzed were the initial and absolute claudication distances as

Omega-3 fatty acids for intermittent claudication.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

BACKGROUND Omega-3 fatty acids have been used in the treatment and prevention of coronary artery disease although current evidence suggests they may be of limited benefit. Peripheral arterial disease and coronary artery disease share a similar pathogenesis so omega-3 fatty acids may have a similar

Prostanoids for intermittent claudication.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

BACKGROUND Peripheral arterial disease (PAD) is a common cause of morbidity in the general population. While numerous studies have established the efficacy of prostanoids in PAD stages III and IV, the question of the role of prostanoids as an alternative or additive treatment in patients suffering

Pentoxifylline for intermittent claudication.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Intermittent claudication (IC) is a symptom of peripheral arterial disease (PAD) and is associated with high morbidity and mortality. Pentoxifylline, one of many drugs used to treat IC, acts by decreasing blood viscosity, improving erythrocyte flexibility and promoting microcirculatory flow and

[Intestinal necrosis as clinical presentation of Takayasu arteritis].

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

A 32 years old female was admitted to hospital due to acute abdominal pain, nausea, vomiting and liquid stools. Physical examination was normal except for pain on her left inferior abdominal quadrant without peritoneal irritation signs. An abdominal CAT-scan suggested thrombosis at celiac trunk,

Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Beraprost sodium (beraprost) is a stable, orally active prostacyclin analogue with vasodilatory, antiplatelet and cytoprotective effects. Beraprost acts by binding to prostacyclin membrane receptors ultimately inhibiting the release of Ca2+ from intracellular storage sites. This reduction in the

Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

A study was carried out in 127 patients (94 males and 33 females) presenting with arteriosclerosis (88 patients) or diabetic vasculopathy (39 patients) in different stages of severity (Fontaine) to assess the effectiveness and tolerance of treatment with high doses of pentoxifylline. Patients

Relief of Lower Back and Leg Pain after Myelography.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

BACKGROUND It is well-known that many patients will have adverse reactions such as headache and nausea after undergoing myelography, but we have often seen cases where symptoms such as lower back pain and leg pain were alleviated following myelography. To the best of our knowledge, such clinical

Analysis of the cilostazol safety database.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Cilostazol, a type III phosphodiesterase inhibitor, was approved in the United States in 1999 for the reduction of the symptoms of intermittent claudication. This article summarizes the safety data from 8 cilostazol phase 3 controlled clinical trials, involving 2,702 patients: 1,374 receiving

A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies.

Samo registrirani korisnici mogu prevoditi članke

Prijava Registriraj se

Systematic reviews and meta-analyses represent the uppermost ladders in the hierarchy of evidence. Systematic reviews/meta-analyses suggest preliminary or satisfactory clinical evidence for agnus castus (Vitex agnus castus) for premenstrual complaints, flaxseed (Linum usitatissimum) for

Pridružite se našoj
facebook stranici

Herbal & Natural Medicine

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

Radi na 55 jezika
Biljni lijekovi potpomognuti znanošću
Prepoznavanje bilja slikom
Interaktivna GPS karta - označite bilje na mjestu (uskoro)
Pročitajte znanstvene publikacije povezane s vašom pretragom
Pretražite ljekovito bilje po učincima
Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima